JOURNAL OF CELLULAR PHYSIOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=899637, encodeId=c8b389963ef8, content=审稿速度:1.0 | 投稿命中率:100.0 偏重的研究方向：生物信息学;细胞信号 经验分享：这个杂志大家要小心！！上面的造假文章太多，担心未来会象tumor biology一样被踢出！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Nov 16 17:38:51 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813016, encodeId=397981301616, content=一个纯生信灌水文章竟然可以发5.5的文章，真是让人大跌眼镜…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/b3be00fb2b6b622306fe07fd2356b7ac.jpg, createdBy=fb132163002, createdName=碧雪凝冰, createdTime=Tue Aug 25 11:31:29 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911896, encodeId=2413911896e0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：杂志reviewer评审意见还是很专业 20年文章降到800篇左右 IF应该5.5左右，还是不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14b51735381, createdName=1def8fe4m63(暂无匿称), createdTime=Tue Dec 29 13:51:32 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590970, encodeId=ab765909e07c, content=兄弟，原始条带一定要带marker 不能剪膜吗？接收了吗？pengpengda 2020-04-16 发表:: 兄弟我和你一样，都提供原始条带了，又给我送三审了。pengpengda 2020-04-16 00:00:00 发表: 兄弟我和你一样，都提供原始条带了，又给我送三审了。, beContent=pengpengda 2020-04-16 发表:: 兄弟我和你一样，都提供原始条带了，又给我送三审了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93d1711201, createdName=今天我是陈懒啊, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588361, encodeId=f5ba588361a2, content=是的，带marker的xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, beContent=xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/7b5dd2943b07723aa1eba8b77034f6bc.jpg, createdBy=475c2155885, createdName=pengpengda, createdTime=Tue Apr 07 00:00:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902790, encodeId=d367902e90cb, content=太悲剧了，投稿的时候，没注意，ORCID里面内容是空的。直接投稿第二天拒稿了。很悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/30/4740c2a2ed5dda79cd71af42dffdab88.jpg, createdBy=10182059629, createdName=攻受兼备, createdTime=Fri Nov 27 13:03:35 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894519, encodeId=af29894519b6, content=这杂志这二年扩刊严重啊，且质量下滑厉害！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Mon Oct 26 13:01:43 CST 2020, time=2020-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800405, encodeId=99e48004056a, content=5.546，今年的，很幸运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Jun 29 21:31:30 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805740, encodeId=2ce2805e4027, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：终于接受了要感动哭，三审大修每次都是不同审稿人，但还是很认真修稿的，前后七个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJD9vGdQ95mlTbM9FyRV4IJOVvfnJVy0RJnUFCGSXd8tqRv7xJn87L86IISWpGQsWGFRLBcf5myUw/132, createdBy=ba992578510, createdName=华灯初上123, createdTime=Sun Aug 02 16:11:58 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893225, encodeId=8b69893225ed, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：我是今年9.2接收，9.12给的doi号，到现在还没有proof，大家遇到过吗？给谁写信询问呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Tue Oct 20 08:42:46 CST 2020, time=2020-10-20, status=1, ipAttribution=)]

2020-11-16 lovetcm

审稿速度:1.0 | 投稿命中率:100.0
偏重的研究方向：生物信息学;细胞信号
经验分享：这个杂志大家要小心！！上面的造假文章太多，担心未来会象tumor biology一样被踢出！

305 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=899637, encodeId=c8b389963ef8, content=审稿速度:1.0 | 投稿命中率:100.0 偏重的研究方向：生物信息学;细胞信号 经验分享：这个杂志大家要小心！！上面的造假文章太多，担心未来会象tumor biology一样被踢出！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Nov 16 17:38:51 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813016, encodeId=397981301616, content=一个纯生信灌水文章竟然可以发5.5的文章，真是让人大跌眼镜…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/b3be00fb2b6b622306fe07fd2356b7ac.jpg, createdBy=fb132163002, createdName=碧雪凝冰, createdTime=Tue Aug 25 11:31:29 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911896, encodeId=2413911896e0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：杂志reviewer评审意见还是很专业 20年文章降到800篇左右 IF应该5.5左右，还是不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14b51735381, createdName=1def8fe4m63(暂无匿称), createdTime=Tue Dec 29 13:51:32 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590970, encodeId=ab765909e07c, content=兄弟，原始条带一定要带marker 不能剪膜吗？接收了吗？pengpengda 2020-04-16 发表:: 兄弟我和你一样，都提供原始条带了，又给我送三审了。pengpengda 2020-04-16 00:00:00 发表: 兄弟我和你一样，都提供原始条带了，又给我送三审了。, beContent=pengpengda 2020-04-16 发表:: 兄弟我和你一样，都提供原始条带了，又给我送三审了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93d1711201, createdName=今天我是陈懒啊, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588361, encodeId=f5ba588361a2, content=是的，带marker的xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, beContent=xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/7b5dd2943b07723aa1eba8b77034f6bc.jpg, createdBy=475c2155885, createdName=pengpengda, createdTime=Tue Apr 07 00:00:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902790, encodeId=d367902e90cb, content=太悲剧了，投稿的时候，没注意，ORCID里面内容是空的。直接投稿第二天拒稿了。很悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/30/4740c2a2ed5dda79cd71af42dffdab88.jpg, createdBy=10182059629, createdName=攻受兼备, createdTime=Fri Nov 27 13:03:35 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894519, encodeId=af29894519b6, content=这杂志这二年扩刊严重啊，且质量下滑厉害！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Mon Oct 26 13:01:43 CST 2020, time=2020-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800405, encodeId=99e48004056a, content=5.546，今年的，很幸运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Jun 29 21:31:30 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805740, encodeId=2ce2805e4027, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：终于接受了要感动哭，三审大修每次都是不同审稿人，但还是很认真修稿的，前后七个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJD9vGdQ95mlTbM9FyRV4IJOVvfnJVy0RJnUFCGSXd8tqRv7xJn87L86IISWpGQsWGFRLBcf5myUw/132, createdBy=ba992578510, createdName=华灯初上123, createdTime=Sun Aug 02 16:11:58 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893225, encodeId=8b69893225ed, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：我是今年9.2接收，9.12给的doi号，到现在还没有proof，大家遇到过吗？给谁写信询问呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Tue Oct 20 08:42:46 CST 2020, time=2020-10-20, status=1, ipAttribution=)]

2020-08-25 碧雪凝冰

一个纯生信灌水文章竟然可以发5.5的文章，真是让人大跌眼镜…

12 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=899637, encodeId=c8b389963ef8, content=审稿速度:1.0 | 投稿命中率:100.0 偏重的研究方向：生物信息学;细胞信号 经验分享：这个杂志大家要小心！！上面的造假文章太多，担心未来会象tumor biology一样被踢出！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Nov 16 17:38:51 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813016, encodeId=397981301616, content=一个纯生信灌水文章竟然可以发5.5的文章，真是让人大跌眼镜…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/b3be00fb2b6b622306fe07fd2356b7ac.jpg, createdBy=fb132163002, createdName=碧雪凝冰, createdTime=Tue Aug 25 11:31:29 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911896, encodeId=2413911896e0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：杂志reviewer评审意见还是很专业 20年文章降到800篇左右 IF应该5.5左右，还是不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14b51735381, createdName=1def8fe4m63(暂无匿称), createdTime=Tue Dec 29 13:51:32 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590970, encodeId=ab765909e07c, content=兄弟，原始条带一定要带marker 不能剪膜吗？接收了吗？pengpengda 2020-04-16 发表:: 兄弟我和你一样，都提供原始条带了，又给我送三审了。pengpengda 2020-04-16 00:00:00 发表: 兄弟我和你一样，都提供原始条带了，又给我送三审了。, beContent=pengpengda 2020-04-16 发表:: 兄弟我和你一样，都提供原始条带了，又给我送三审了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93d1711201, createdName=今天我是陈懒啊, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588361, encodeId=f5ba588361a2, content=是的，带marker的xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, beContent=xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/7b5dd2943b07723aa1eba8b77034f6bc.jpg, createdBy=475c2155885, createdName=pengpengda, createdTime=Tue Apr 07 00:00:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902790, encodeId=d367902e90cb, content=太悲剧了，投稿的时候，没注意，ORCID里面内容是空的。直接投稿第二天拒稿了。很悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/30/4740c2a2ed5dda79cd71af42dffdab88.jpg, createdBy=10182059629, createdName=攻受兼备, createdTime=Fri Nov 27 13:03:35 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894519, encodeId=af29894519b6, content=这杂志这二年扩刊严重啊，且质量下滑厉害！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Mon Oct 26 13:01:43 CST 2020, time=2020-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800405, encodeId=99e48004056a, content=5.546，今年的，很幸运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Jun 29 21:31:30 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805740, encodeId=2ce2805e4027, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：终于接受了要感动哭，三审大修每次都是不同审稿人，但还是很认真修稿的，前后七个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJD9vGdQ95mlTbM9FyRV4IJOVvfnJVy0RJnUFCGSXd8tqRv7xJn87L86IISWpGQsWGFRLBcf5myUw/132, createdBy=ba992578510, createdName=华灯初上123, createdTime=Sun Aug 02 16:11:58 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893225, encodeId=8b69893225ed, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：我是今年9.2接收，9.12给的doi号，到现在还没有proof，大家遇到过吗？给谁写信询问呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Tue Oct 20 08:42:46 CST 2020, time=2020-10-20, status=1, ipAttribution=)]

2020-12-29 1def8fe4m63(暂无匿称)

审稿速度:3.0 | 投稿命中率:50.0
经验分享：杂志reviewer评审意见还是很专业 20年文章降到800篇左右 IF应该5.5左右，还是不错的杂志

438 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=899637, encodeId=c8b389963ef8, content=审稿速度:1.0 | 投稿命中率:100.0 偏重的研究方向：生物信息学;细胞信号 经验分享：这个杂志大家要小心！！上面的造假文章太多，担心未来会象tumor biology一样被踢出！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Nov 16 17:38:51 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813016, encodeId=397981301616, content=一个纯生信灌水文章竟然可以发5.5的文章，真是让人大跌眼镜…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/b3be00fb2b6b622306fe07fd2356b7ac.jpg, createdBy=fb132163002, createdName=碧雪凝冰, createdTime=Tue Aug 25 11:31:29 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911896, encodeId=2413911896e0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：杂志reviewer评审意见还是很专业 20年文章降到800篇左右 IF应该5.5左右，还是不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14b51735381, createdName=1def8fe4m63(暂无匿称), createdTime=Tue Dec 29 13:51:32 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590970, encodeId=ab765909e07c, content=兄弟，原始条带一定要带marker 不能剪膜吗？接收了吗？pengpengda 2020-04-16 发表:: 兄弟我和你一样，都提供原始条带了，又给我送三审了。pengpengda 2020-04-16 00:00:00 发表: 兄弟我和你一样，都提供原始条带了，又给我送三审了。, beContent=pengpengda 2020-04-16 发表:: 兄弟我和你一样，都提供原始条带了，又给我送三审了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93d1711201, createdName=今天我是陈懒啊, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588361, encodeId=f5ba588361a2, content=是的，带marker的xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, beContent=xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/7b5dd2943b07723aa1eba8b77034f6bc.jpg, createdBy=475c2155885, createdName=pengpengda, createdTime=Tue Apr 07 00:00:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902790, encodeId=d367902e90cb, content=太悲剧了，投稿的时候，没注意，ORCID里面内容是空的。直接投稿第二天拒稿了。很悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/30/4740c2a2ed5dda79cd71af42dffdab88.jpg, createdBy=10182059629, createdName=攻受兼备, createdTime=Fri Nov 27 13:03:35 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894519, encodeId=af29894519b6, content=这杂志这二年扩刊严重啊，且质量下滑厉害！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Mon Oct 26 13:01:43 CST 2020, time=2020-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800405, encodeId=99e48004056a, content=5.546，今年的，很幸运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Jun 29 21:31:30 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805740, encodeId=2ce2805e4027, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：终于接受了要感动哭，三审大修每次都是不同审稿人，但还是很认真修稿的，前后七个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJD9vGdQ95mlTbM9FyRV4IJOVvfnJVy0RJnUFCGSXd8tqRv7xJn87L86IISWpGQsWGFRLBcf5myUw/132, createdBy=ba992578510, createdName=华灯初上123, createdTime=Sun Aug 02 16:11:58 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893225, encodeId=8b69893225ed, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：我是今年9.2接收，9.12给的doi号，到现在还没有proof，大家遇到过吗？给谁写信询问呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Tue Oct 20 08:42:46 CST 2020, time=2020-10-20, status=1, ipAttribution=)]

2020-05-16 今天我是陈懒啊

兄弟，原始条带一定要带marker 不能剪膜吗？接收了吗？pengpengda 2020-04-16 发表::
兄弟我和你一样，都提供原始条带了，又给我送三审了。pengpengda 2020-04-16 00:00:00 发表:
兄弟我和你一样，都提供原始条带了，又给我送三审了。

pengpengda 2020-04-16 发表:: 兄弟我和你一样，都提供原始条带了，又给我送三审了。

149 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=899637, encodeId=c8b389963ef8, content=审稿速度:1.0 | 投稿命中率:100.0 偏重的研究方向：生物信息学;细胞信号 经验分享：这个杂志大家要小心！！上面的造假文章太多，担心未来会象tumor biology一样被踢出！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Nov 16 17:38:51 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813016, encodeId=397981301616, content=一个纯生信灌水文章竟然可以发5.5的文章，真是让人大跌眼镜…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/b3be00fb2b6b622306fe07fd2356b7ac.jpg, createdBy=fb132163002, createdName=碧雪凝冰, createdTime=Tue Aug 25 11:31:29 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911896, encodeId=2413911896e0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：杂志reviewer评审意见还是很专业 20年文章降到800篇左右 IF应该5.5左右，还是不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14b51735381, createdName=1def8fe4m63(暂无匿称), createdTime=Tue Dec 29 13:51:32 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590970, encodeId=ab765909e07c, content=兄弟，原始条带一定要带marker 不能剪膜吗？接收了吗？pengpengda 2020-04-16 发表:: 兄弟我和你一样，都提供原始条带了，又给我送三审了。pengpengda 2020-04-16 00:00:00 发表: 兄弟我和你一样，都提供原始条带了，又给我送三审了。, beContent=pengpengda 2020-04-16 发表:: 兄弟我和你一样，都提供原始条带了，又给我送三审了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93d1711201, createdName=今天我是陈懒啊, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588361, encodeId=f5ba588361a2, content=是的，带marker的xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, beContent=xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/7b5dd2943b07723aa1eba8b77034f6bc.jpg, createdBy=475c2155885, createdName=pengpengda, createdTime=Tue Apr 07 00:00:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902790, encodeId=d367902e90cb, content=太悲剧了，投稿的时候，没注意，ORCID里面内容是空的。直接投稿第二天拒稿了。很悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/30/4740c2a2ed5dda79cd71af42dffdab88.jpg, createdBy=10182059629, createdName=攻受兼备, createdTime=Fri Nov 27 13:03:35 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894519, encodeId=af29894519b6, content=这杂志这二年扩刊严重啊，且质量下滑厉害！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Mon Oct 26 13:01:43 CST 2020, time=2020-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800405, encodeId=99e48004056a, content=5.546，今年的，很幸运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Jun 29 21:31:30 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805740, encodeId=2ce2805e4027, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：终于接受了要感动哭，三审大修每次都是不同审稿人，但还是很认真修稿的，前后七个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJD9vGdQ95mlTbM9FyRV4IJOVvfnJVy0RJnUFCGSXd8tqRv7xJn87L86IISWpGQsWGFRLBcf5myUw/132, createdBy=ba992578510, createdName=华灯初上123, createdTime=Sun Aug 02 16:11:58 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893225, encodeId=8b69893225ed, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：我是今年9.2接收，9.12给的doi号，到现在还没有proof，大家遇到过吗？给谁写信询问呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Tue Oct 20 08:42:46 CST 2020, time=2020-10-20, status=1, ipAttribution=)]

2020-04-07 pengpengda

是的，带marker的xiaobinyisheng 2020-04-07 00:00:00 发表:
你的原始条带是未切割的吗？带有marker吗？

xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？

136 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=899637, encodeId=c8b389963ef8, content=审稿速度:1.0 | 投稿命中率:100.0 偏重的研究方向：生物信息学;细胞信号 经验分享：这个杂志大家要小心！！上面的造假文章太多，担心未来会象tumor biology一样被踢出！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Nov 16 17:38:51 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813016, encodeId=397981301616, content=一个纯生信灌水文章竟然可以发5.5的文章，真是让人大跌眼镜…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/b3be00fb2b6b622306fe07fd2356b7ac.jpg, createdBy=fb132163002, createdName=碧雪凝冰, createdTime=Tue Aug 25 11:31:29 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911896, encodeId=2413911896e0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：杂志reviewer评审意见还是很专业 20年文章降到800篇左右 IF应该5.5左右，还是不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14b51735381, createdName=1def8fe4m63(暂无匿称), createdTime=Tue Dec 29 13:51:32 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590970, encodeId=ab765909e07c, content=兄弟，原始条带一定要带marker 不能剪膜吗？接收了吗？pengpengda 2020-04-16 发表:: 兄弟我和你一样，都提供原始条带了，又给我送三审了。pengpengda 2020-04-16 00:00:00 发表: 兄弟我和你一样，都提供原始条带了，又给我送三审了。, beContent=pengpengda 2020-04-16 发表:: 兄弟我和你一样，都提供原始条带了，又给我送三审了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93d1711201, createdName=今天我是陈懒啊, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588361, encodeId=f5ba588361a2, content=是的，带marker的xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, beContent=xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/7b5dd2943b07723aa1eba8b77034f6bc.jpg, createdBy=475c2155885, createdName=pengpengda, createdTime=Tue Apr 07 00:00:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902790, encodeId=d367902e90cb, content=太悲剧了，投稿的时候，没注意，ORCID里面内容是空的。直接投稿第二天拒稿了。很悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/30/4740c2a2ed5dda79cd71af42dffdab88.jpg, createdBy=10182059629, createdName=攻受兼备, createdTime=Fri Nov 27 13:03:35 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894519, encodeId=af29894519b6, content=这杂志这二年扩刊严重啊，且质量下滑厉害！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Mon Oct 26 13:01:43 CST 2020, time=2020-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800405, encodeId=99e48004056a, content=5.546，今年的，很幸运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Jun 29 21:31:30 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805740, encodeId=2ce2805e4027, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：终于接受了要感动哭，三审大修每次都是不同审稿人，但还是很认真修稿的，前后七个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJD9vGdQ95mlTbM9FyRV4IJOVvfnJVy0RJnUFCGSXd8tqRv7xJn87L86IISWpGQsWGFRLBcf5myUw/132, createdBy=ba992578510, createdName=华灯初上123, createdTime=Sun Aug 02 16:11:58 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893225, encodeId=8b69893225ed, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：我是今年9.2接收，9.12给的doi号，到现在还没有proof，大家遇到过吗？给谁写信询问呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Tue Oct 20 08:42:46 CST 2020, time=2020-10-20, status=1, ipAttribution=)]

2020-11-27 攻受兼备

太悲剧了，投稿的时候，没注意，ORCID里面内容是空的。直接投稿第二天拒稿了。很悲剧

119 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=899637, encodeId=c8b389963ef8, content=审稿速度:1.0 | 投稿命中率:100.0 偏重的研究方向：生物信息学;细胞信号 经验分享：这个杂志大家要小心！！上面的造假文章太多，担心未来会象tumor biology一样被踢出！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Nov 16 17:38:51 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813016, encodeId=397981301616, content=一个纯生信灌水文章竟然可以发5.5的文章，真是让人大跌眼镜…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/b3be00fb2b6b622306fe07fd2356b7ac.jpg, createdBy=fb132163002, createdName=碧雪凝冰, createdTime=Tue Aug 25 11:31:29 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911896, encodeId=2413911896e0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：杂志reviewer评审意见还是很专业 20年文章降到800篇左右 IF应该5.5左右，还是不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14b51735381, createdName=1def8fe4m63(暂无匿称), createdTime=Tue Dec 29 13:51:32 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590970, encodeId=ab765909e07c, content=兄弟，原始条带一定要带marker 不能剪膜吗？接收了吗？pengpengda 2020-04-16 发表:: 兄弟我和你一样，都提供原始条带了，又给我送三审了。pengpengda 2020-04-16 00:00:00 发表: 兄弟我和你一样，都提供原始条带了，又给我送三审了。, beContent=pengpengda 2020-04-16 发表:: 兄弟我和你一样，都提供原始条带了，又给我送三审了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93d1711201, createdName=今天我是陈懒啊, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588361, encodeId=f5ba588361a2, content=是的，带marker的xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, beContent=xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/7b5dd2943b07723aa1eba8b77034f6bc.jpg, createdBy=475c2155885, createdName=pengpengda, createdTime=Tue Apr 07 00:00:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902790, encodeId=d367902e90cb, content=太悲剧了，投稿的时候，没注意，ORCID里面内容是空的。直接投稿第二天拒稿了。很悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/30/4740c2a2ed5dda79cd71af42dffdab88.jpg, createdBy=10182059629, createdName=攻受兼备, createdTime=Fri Nov 27 13:03:35 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894519, encodeId=af29894519b6, content=这杂志这二年扩刊严重啊，且质量下滑厉害！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Mon Oct 26 13:01:43 CST 2020, time=2020-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800405, encodeId=99e48004056a, content=5.546，今年的，很幸运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Jun 29 21:31:30 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805740, encodeId=2ce2805e4027, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：终于接受了要感动哭，三审大修每次都是不同审稿人，但还是很认真修稿的，前后七个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJD9vGdQ95mlTbM9FyRV4IJOVvfnJVy0RJnUFCGSXd8tqRv7xJn87L86IISWpGQsWGFRLBcf5myUw/132, createdBy=ba992578510, createdName=华灯初上123, createdTime=Sun Aug 02 16:11:58 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893225, encodeId=8b69893225ed, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：我是今年9.2接收，9.12给的doi号，到现在还没有proof，大家遇到过吗？给谁写信询问呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Tue Oct 20 08:42:46 CST 2020, time=2020-10-20, status=1, ipAttribution=)]

2020-10-26 Rtase

这杂志这二年扩刊严重啊，且质量下滑厉害！

168 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=899637, encodeId=c8b389963ef8, content=审稿速度:1.0 | 投稿命中率:100.0 偏重的研究方向：生物信息学;细胞信号 经验分享：这个杂志大家要小心！！上面的造假文章太多，担心未来会象tumor biology一样被踢出！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Nov 16 17:38:51 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813016, encodeId=397981301616, content=一个纯生信灌水文章竟然可以发5.5的文章，真是让人大跌眼镜…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/b3be00fb2b6b622306fe07fd2356b7ac.jpg, createdBy=fb132163002, createdName=碧雪凝冰, createdTime=Tue Aug 25 11:31:29 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911896, encodeId=2413911896e0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：杂志reviewer评审意见还是很专业 20年文章降到800篇左右 IF应该5.5左右，还是不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14b51735381, createdName=1def8fe4m63(暂无匿称), createdTime=Tue Dec 29 13:51:32 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590970, encodeId=ab765909e07c, content=兄弟，原始条带一定要带marker 不能剪膜吗？接收了吗？pengpengda 2020-04-16 发表:: 兄弟我和你一样，都提供原始条带了，又给我送三审了。pengpengda 2020-04-16 00:00:00 发表: 兄弟我和你一样，都提供原始条带了，又给我送三审了。, beContent=pengpengda 2020-04-16 发表:: 兄弟我和你一样，都提供原始条带了，又给我送三审了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93d1711201, createdName=今天我是陈懒啊, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588361, encodeId=f5ba588361a2, content=是的，带marker的xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, beContent=xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/7b5dd2943b07723aa1eba8b77034f6bc.jpg, createdBy=475c2155885, createdName=pengpengda, createdTime=Tue Apr 07 00:00:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902790, encodeId=d367902e90cb, content=太悲剧了，投稿的时候，没注意，ORCID里面内容是空的。直接投稿第二天拒稿了。很悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/30/4740c2a2ed5dda79cd71af42dffdab88.jpg, createdBy=10182059629, createdName=攻受兼备, createdTime=Fri Nov 27 13:03:35 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894519, encodeId=af29894519b6, content=这杂志这二年扩刊严重啊，且质量下滑厉害！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Mon Oct 26 13:01:43 CST 2020, time=2020-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800405, encodeId=99e48004056a, content=5.546，今年的，很幸运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Jun 29 21:31:30 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805740, encodeId=2ce2805e4027, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：终于接受了要感动哭，三审大修每次都是不同审稿人，但还是很认真修稿的，前后七个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJD9vGdQ95mlTbM9FyRV4IJOVvfnJVy0RJnUFCGSXd8tqRv7xJn87L86IISWpGQsWGFRLBcf5myUw/132, createdBy=ba992578510, createdName=华灯初上123, createdTime=Sun Aug 02 16:11:58 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893225, encodeId=8b69893225ed, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：我是今年9.2接收，9.12给的doi号，到现在还没有proof，大家遇到过吗？给谁写信询问呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Tue Oct 20 08:42:46 CST 2020, time=2020-10-20, status=1, ipAttribution=)]

2020-06-29 mswert122

5.546，今年的，很幸运

140 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=899637, encodeId=c8b389963ef8, content=审稿速度:1.0 | 投稿命中率:100.0 偏重的研究方向：生物信息学;细胞信号 经验分享：这个杂志大家要小心！！上面的造假文章太多，担心未来会象tumor biology一样被踢出！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Nov 16 17:38:51 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813016, encodeId=397981301616, content=一个纯生信灌水文章竟然可以发5.5的文章，真是让人大跌眼镜…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/b3be00fb2b6b622306fe07fd2356b7ac.jpg, createdBy=fb132163002, createdName=碧雪凝冰, createdTime=Tue Aug 25 11:31:29 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911896, encodeId=2413911896e0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：杂志reviewer评审意见还是很专业 20年文章降到800篇左右 IF应该5.5左右，还是不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14b51735381, createdName=1def8fe4m63(暂无匿称), createdTime=Tue Dec 29 13:51:32 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590970, encodeId=ab765909e07c, content=兄弟，原始条带一定要带marker 不能剪膜吗？接收了吗？pengpengda 2020-04-16 发表:: 兄弟我和你一样，都提供原始条带了，又给我送三审了。pengpengda 2020-04-16 00:00:00 发表: 兄弟我和你一样，都提供原始条带了，又给我送三审了。, beContent=pengpengda 2020-04-16 发表:: 兄弟我和你一样，都提供原始条带了，又给我送三审了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93d1711201, createdName=今天我是陈懒啊, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588361, encodeId=f5ba588361a2, content=是的，带marker的xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, beContent=xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/7b5dd2943b07723aa1eba8b77034f6bc.jpg, createdBy=475c2155885, createdName=pengpengda, createdTime=Tue Apr 07 00:00:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902790, encodeId=d367902e90cb, content=太悲剧了，投稿的时候，没注意，ORCID里面内容是空的。直接投稿第二天拒稿了。很悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/30/4740c2a2ed5dda79cd71af42dffdab88.jpg, createdBy=10182059629, createdName=攻受兼备, createdTime=Fri Nov 27 13:03:35 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894519, encodeId=af29894519b6, content=这杂志这二年扩刊严重啊，且质量下滑厉害！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Mon Oct 26 13:01:43 CST 2020, time=2020-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800405, encodeId=99e48004056a, content=5.546，今年的，很幸运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Jun 29 21:31:30 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805740, encodeId=2ce2805e4027, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：终于接受了要感动哭，三审大修每次都是不同审稿人，但还是很认真修稿的，前后七个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJD9vGdQ95mlTbM9FyRV4IJOVvfnJVy0RJnUFCGSXd8tqRv7xJn87L86IISWpGQsWGFRLBcf5myUw/132, createdBy=ba992578510, createdName=华灯初上123, createdTime=Sun Aug 02 16:11:58 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893225, encodeId=8b69893225ed, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：我是今年9.2接收，9.12给的doi号，到现在还没有proof，大家遇到过吗？给谁写信询问呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Tue Oct 20 08:42:46 CST 2020, time=2020-10-20, status=1, ipAttribution=)]

2020-08-02 华灯初上123

审稿速度:3.0 | 投稿命中率:50.0
经验分享：终于接受了要感动哭，三审大修每次都是不同审稿人，但还是很认真修稿的，前后七个多月

117 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=899637, encodeId=c8b389963ef8, content=审稿速度:1.0 | 投稿命中率:100.0 偏重的研究方向：生物信息学;细胞信号 经验分享：这个杂志大家要小心！！上面的造假文章太多，担心未来会象tumor biology一样被踢出！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Nov 16 17:38:51 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813016, encodeId=397981301616, content=一个纯生信灌水文章竟然可以发5.5的文章，真是让人大跌眼镜…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/b3be00fb2b6b622306fe07fd2356b7ac.jpg, createdBy=fb132163002, createdName=碧雪凝冰, createdTime=Tue Aug 25 11:31:29 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911896, encodeId=2413911896e0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：杂志reviewer评审意见还是很专业 20年文章降到800篇左右 IF应该5.5左右，还是不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14b51735381, createdName=1def8fe4m63(暂无匿称), createdTime=Tue Dec 29 13:51:32 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590970, encodeId=ab765909e07c, content=兄弟，原始条带一定要带marker 不能剪膜吗？接收了吗？pengpengda 2020-04-16 发表:: 兄弟我和你一样，都提供原始条带了，又给我送三审了。pengpengda 2020-04-16 00:00:00 发表: 兄弟我和你一样，都提供原始条带了，又给我送三审了。, beContent=pengpengda 2020-04-16 发表:: 兄弟我和你一样，都提供原始条带了，又给我送三审了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93d1711201, createdName=今天我是陈懒啊, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588361, encodeId=f5ba588361a2, content=是的，带marker的xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, beContent=xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/7b5dd2943b07723aa1eba8b77034f6bc.jpg, createdBy=475c2155885, createdName=pengpengda, createdTime=Tue Apr 07 00:00:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902790, encodeId=d367902e90cb, content=太悲剧了，投稿的时候，没注意，ORCID里面内容是空的。直接投稿第二天拒稿了。很悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/30/4740c2a2ed5dda79cd71af42dffdab88.jpg, createdBy=10182059629, createdName=攻受兼备, createdTime=Fri Nov 27 13:03:35 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894519, encodeId=af29894519b6, content=这杂志这二年扩刊严重啊，且质量下滑厉害！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Mon Oct 26 13:01:43 CST 2020, time=2020-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800405, encodeId=99e48004056a, content=5.546，今年的，很幸运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Jun 29 21:31:30 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805740, encodeId=2ce2805e4027, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：终于接受了要感动哭，三审大修每次都是不同审稿人，但还是很认真修稿的，前后七个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJD9vGdQ95mlTbM9FyRV4IJOVvfnJVy0RJnUFCGSXd8tqRv7xJn87L86IISWpGQsWGFRLBcf5myUw/132, createdBy=ba992578510, createdName=华灯初上123, createdTime=Sun Aug 02 16:11:58 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893225, encodeId=8b69893225ed, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：我是今年9.2接收，9.12给的doi号，到现在还没有proof，大家遇到过吗？给谁写信询问呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Tue Oct 20 08:42:46 CST 2020, time=2020-10-20, status=1, ipAttribution=)]

2020-10-20 sunyong_97

审稿速度:2.0 | 投稿命中率:50.0
经验分享：我是今年9.2接收，9.12给的doi号，到现在还没有proof，大家遇到过吗？给谁写信询问呢？

64 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务